Skip to main content

Topic

Marketing Authorisation

30 published works

  1. BioSlice Blog

    European Commission Publishes New Variation Guidelines for Medicines

    By Alexander Roussanov, Ana Gonzalez-Lamuno

    The European Commission has published new Guidelines on the details of the various categories of variations (to the terms of marketing authorisations (“MA”) for medicinal products) (“Variations Guidelines”). The new…

  2. The Continuum of Risk

    FDA Issues First Marketing Authorization for Oral Nicotine Pouches

    By Azim Chowdhury, Neelam Gill

    In a groundbreaking move, FDA has kicked off the year with its very first marketing authorization for an oral nicotine pouch product. On January 16, 2025, FDA authorized twenty ZYN…

  3. Regulatory Oversight

    Vape Companies Challenge Iowa’s New Vape Directory Law

    By Agustin Rodriguez, Nick Ramos

    On December 17, 2024, Iowans for Alternatives to Smoking & Tobacco, Inc., Global Source Distribution, LLC, and others filed a complaint[1] and motion for a preliminary injunction[2] in federal district…

  4. Big Molecule Watch

    EMA Accepts Marketing Authorization Application for Alvotech’s AVT05 (golimumab)

    By Tara Thigpen

    On November 4, 2024, Alvotech and Advanz Pharma announced that the European Medicines Agency (EMA) has accepted a Marketing Authorization Application for AVT05, Alvotech’s biosimilar to Simponi® (golimumab), for the…

  5. Big Molecule Watch

    Outlook Therapeutics Announces UK MHRA Marketing Authorization of LYTENAVA™ (bevacizumab gamma)

    By Lihui Bai

    On July 08, 2024, Outlook Therapeutics announced it received marketing authorization from UK Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment of wet AMD in the UK.  As…

  6. Global Regulation Tomorrow

    FCA updates webpage on landing slots for funds in temporary marketing permissions regime

    By Simon Lovegrove (UK), Anita Edwards

    On 9 October 2023, the FCA updated its webpage on landing slots for funds in the temporary marketing permissions regime (TMPR). The webpage explains that the process of exiting the…

  7. Global Regulation Tomorrow

    FCA publishes new webpage: Landing slots for funds in temporary marketing permissions regime

    By Simon Lovegrove (UK), Anita Edwards

    On 19 September 2023, the FCA published a new webpage on landing slots for funds in the temporary marketing permissions regime (TMPR). The webpage explains that, in the coming months,…

  8. Global Policy Watch

    EU Pharma Legislation Review Series: Temporary Emergency Marketing Authorizations

    By Sarah Cowlishaw

    Following the COVID-19 pandemic and the relatively slow approval of vaccines in the EU versus other key jurisdictions, as part of the EU’s General Pharmaceutical Legislation amendment proposal, published on 26 April 2023,…

  9. Inside EU Life Sciences

    EU Pharma Legislation Review Series: Temporary Emergency Marketing Authorizations

    By Sarah Cowlishaw

    Following the COVID-19 pandemic and the relatively slow approval of vaccines in the EU versus other key jurisdictions, as part of the EU’s General Pharmaceutical Legislation amendment proposal, published on 26…

  10. Inside EU Life Sciences

    EU Pharma Legislation Review Series: Marketing Authorisations

    By Marie Doyle-Rossi, Grant Castle

    The European Commission’s proposal to amend the EU's general pharmaceutical legislation includes a new draft directive replacing Directive 2001/83/EC (the draft Directive) and a new draft regulation replacing Regulation (EC)…